Troy A. Ignelzi, Chief Financial Officer at Karuna Therapeutics, Inc. (KRTX), sold 1,834 shares at $201.41 ($369K) on 2023-01-17, disclosed to the SEC on 2023-01-19.
Open-market sale of $369k KRTX by Chief Financial Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $201.41 | 817 | $165K | 44.6% |
| 2 | $201.41 | 817 | $165K | 44.6% |
| 3 | $200.14 | 200 | $40K | 10.8% |
| Total | $201.27 avg | 1,834 | $369K | 100% |
| Filing → |
| KRTX | SELL | 2023-05-25 | $4.0M | — | Filing → |
| KRTX | SELL | 2023-02-23 | $1.1M | — | Filing → |
| KRTX | SELL | 2022-11-17 | $3.7M | — | Filing → |